deficiency lectin shown risk factor cystic fibrosis cf patients decided treat patient cf lectin deficiency severe bronchopulmonary pseudomonas aeruginosa infection rapid deterioration lung function purified lectin attempt ameliorate course lung disease lectin used originated pooled human donor plasma given intravenous infusion twice week period NUMBER months patientss clinical condition stabilized treatment period improved adverse events observed lung function assessed percent forced expiratory volume NUMBER sec fev1 percent forced vital capacirt fvc correlated significantly serum lectin levels rho068 p0008 rho073 p0004 additionally inverse correlation acute creactive protein proinflammatory cytokine observed p0007 p004 respectively results emphasize importance lectin secondary disease modifier cf purified lectin safely administered chronically ill patients potential treatment cf diseases lectin deficiency plays pathophysiological role copyright NUMBER mannose binding mannose binding mannose binding mannose binding mannose binding phase reactant il NUMBER rho NUMBER rho NUMBER mannose binding mannose binding mannose binding wiley liss